To: Paul Senior who wrote (2920 ) 1/6/1998 12:48:00 PM From: Richard Barron Read Replies (4) | Respond to of 78714
Paul, Thank you for the compliment. You must be pretty thorough to have researched back to post #85!!!. I try and figure out which stocks are undervalued with decent growth, or return 15% by staying steady. I also trade REIT's. The easiest way to make money on value stocks it find a bucket of stocks growing by 25% or more and trading at 12 times earnings or less. I also look for any growth with a P/E under 7, and ones trading at less than 70% of book value. I look at every earnings report in IBD every day to screen the stocks. Currently some examples: ACTC - growth slowed to 50% earnings growth in the last quarter, and P/E is under 15 now. Consolidater with huge growth. I will buy more under 4. ADAM - turnaround potential 2 quarters of earnings after years of losses. Am waiting for 3rd quarter report, but if .07 or more, I may accumulate. ADEX- Low P/E in a company that shows it can grow. Will buy more near 16. ALPH - buy near 11: recovered strong in last few weeks. Decent growth over last few years. This is taking to long, I'll just list the rest and why it is a decent value. APPB- consistent growth, low P/E. BMLS- 70% of book, low P/E. DSWLF- *** - most undervalued stock on the market. Safest to build a position slowly or accumualte on a breakout above 19. Waiting for next earnings report will show effects of Asian problems if any. 35% earnings growth with a P/E under 8. Pretty incredible value. ELXS-Great management, very low P/E 5 years 15%+earnings growth. GES- Very Low P/E ISTN - accelerating growth, am trying to buy below 9 MAX-low P/E after one bankrupt customer writeoff backed out. MEOHF-very low P/E. NMGC-*** Huge growth P/E- less than 15 on last quarters earnings rate, looks to me like they are blowing away any competition. OO- President bought another million shares at prices near these levels showing high confidence in long term prospects. PTNX- Very low P/E with flat revenues. Apparently revenues may accelerate QGLY- risky, but huge growth with low P/E. Must be scared of competition hurting their margins.Stock has been very weak SBEI- risky, looks great except flat revenues in last quarter and very weak stock price. Very low P/E with huge year over year growth. VIP- Risky, russian company. low P/E strong growth. currency worries. ZILA- biotech that is breaking even and consolidating industry of dental supply distribution and lots of potential for a cancer detecting agent for mouth cancer. If the agent gets FDA approval, this could go up 3-10 fold in a few years. If not, The company may be able to be worth 50-100% of current price in 2 years or less by new growth. here are the huge potenetial winners that I am waiting for another earnings report that have huge growth. ADVH - 100%+ revenue growth, price is 25% cheaper than it was 5 months ago. DHSM - 100%+ revenue growth . I'll buy under 10 ESCMF- 200%+ revenue growth. I'll buy under 35. MODT- 100%+revenue growth. I'll buy under 20. NTAIF- risky since revenues dropped quarter over quarter. Very Low P/E SCSC- just following XC-Just following, low P/E, great insider buying also. regards, I also follow HDCO, IDTC, INVX, Richard